RT @AurelieRheumo: Double hitâ: #OP0015 Phase IIA ABBV-3373 (Adalimumab linked to GC receptor modulator GRM) vs. PBO a

Social Author Image

https://pbs.twimg.com/profile_images/1194991303307747335/hZjMpBuI.jpg

Tweet Author

Social Author Name

Aurelie Najm

Tweet Content

Double hit”: #OP0015 Phase IIA ABBV-3373 (Adalimumab linked to GC receptor modulator GRM) vs. PBO and historic ADA show promising results with a satisfactory safety profile compared to ADA. A potential new IV drug in RA! #EULAR2021 @Rheumnow https://t.co/mqLtXx9zBI

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @AurelieRheumo: Double hitâ: #OP0015 Phase IIA ABBV-3373 (Adalimumab linked to GC receptor modulator GRM) vs. PBO a

Do you get our email newsletter?

RT @AurelieRheumo: Double hitâ: #OP0015 Phase IIA ABBV-3373 (Adalimumab linked to GC receptor modulator GRM) vs. PBO a

RT @AurelieRheumo: Double hitâ: #OP0015 Phase IIA ABBV-3373 (Adalimumab linked to GC receptor modulator GRM) vs. PBO a